Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study

Pupalan Iyngkaran; Fahad Hanna; Sharon Andrew; John David Horowitz; Malcolm Battersby; Maximilian Pangratius De Courten

doi:10.3389/fmed.2023.1059735

Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study

Front Med (Lausanne). 2023 May 12:10:1059735. doi: 10.3389/fmed.2023.1059735. eCollection 2023.

Authors

Pupalan Iyngkaran^{1

2}, Fahad Hanna³, Sharon Andrew⁴, John David Horowitz⁵, Malcolm Battersby⁶, Maximilian Pangratius De Courten⁷

Affiliations

¹ Heart Failure & Cardiac Imaging, Torrens University, Melbourne, VIC, Australia.
² Werribee Mercy Sub School, School of Medicine, University of Notre Dame, Werribee, VIC, Australia.
³ Public Health, Torrens University Australia, Melbourne, VIC, Australia.
⁴ Institute of Health and Sport, Victoria University, Melbourne, VIC, Australia.
⁵ Basil Hetzel Institute for Translational Health Research, University of Adelaide, Adelaide, SA, Australia.
⁶ Flinders Health and Medical Research Institute, Southern Adelaide Local Health Network Mental Health Service, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.
⁷ Mitchell Institute, Victoria University, Melbourne, VIC, Australia.

Abstract

Introduction: Congestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes.

Methods and analysis: SELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months.

Ethics and dissemination: This study has been approved by the St Vincent's ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications.

Keywords: Flinders program; congestive heart failure; mixed methods research methodology; protocol; risk assessment; self-management.